Author

Ignacio Martin-Loeches

St James's Hospital - Cited by 26,200 - Infection Sepsis ICU

Biography

Dr. Ignacio Martin-Loeches  is currently working in Department of Intensive Care Medicine Hospital de Sabadell, CIBER de Enfermedades Respiratorias, Corporació Sanitaria i Universitaria Parc Taulí, Sabadell, Spain. He has published numerous research papers and articles in reputed journals and has various other achievements in the related studies. He has extended his valuable service towards the scientific community with his extensive research work.
Title
Cited by
Year
Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study
T Pham, L Heunks, G Bellani, F Madotto, I Aragao, G Beduneau, ...The Lancet Respiratory Medicine 11 (5), 465-46, 2023202
7
2023
A Differential Therapeutic consideration for use of Corticosteroids according to Established COVID-19 Clinical Phenotypes in Critically ill Patients
G Moreno, M Ruiz-Botella, I Martin-Loeches, JG Álvarez, MJ Herrera, ...Medicina Intensiva (English Edition) 47 (1), 23-33, 2023202
5
2023
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
C Kartsonaki, JK Baillie, NG Barrio, J Baruch, A Beane, L Blumberg, ...International journal of epidemiology 2 (2), 3-376, 2023202
5
2023
Multimodal strategy to counteract vasodilation in septic shock
M Leone, S Einav, E Antonucci, F Depret, I Lakbar, I Martin-Loeches, ...Anaesthesia Critical Care & Pain Medicine, 101193, 2023202
4
2023
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
I Martin-Loeches, A Torres, B Nagavci, S Aliberti, M Antonelli, M Bassetti, ...Intensive care medicine 9 (6), 615-632, 2023202
4
2023
An artificial neural network classification method employing longitudinally monitored immune biomarkers to predict the clinical outcome of critically ill COVID-19 patients
G Martinez, A Garduno, A Mahmud-Al-Rafat, AT Ostadgavahi, A Avery, ...PeerJ 10, e14487, 2022202
3
2022
Effects of fluids on the sublingual microcirculation in sepsis
R Cusack, S O’Neill, I Martin-LoechesJournal of Clinical Medicine 11 (4), 777, 0
2
2022
Ventilator associated tracheobronchitis and pneumonia: one infection with two faces
I Martin-Loeches, P Povoa, S NseirIntensive Care Medicine, 1-4, 030
2
2023
Clinical features, etiologies, and outcomes in adult patients with meningoencephalitis requiring intensive care (EURECA): an international prospective multicenter cohort study
R Sonneville, E de Montmollin, D Contou, R Ferrer, M Gurjar, K Klouche, ...Intensive Care Medicine 49 (5), 517-59, 030
2
2023
Bronchoscopy for diagnosis of ventilator-associated pneumonia
I Martin-Loeches, J Chastre, RG WunderinkIntensive Care Medicine 49 (1), 79-8, 030
2
2023
Interactions between Gender and Sepsis—Implications for the Future
I Lakbar, S Einav, N Lalevée, I Martin-Loeches, B Pastene, M LeoneMicroorganisms (3), 746, 2023202
1
2023
Endothelial Damage and the Microcirculation in Critical Illness
R Cusack, M Leone, AH Rodriguez, I Martin-LoechesBiomedicines 0 (2), 350, 2022202
1
2022
Not all nebulizers are created equal: Considerations in choosing a nebulizer for aerosol delivery during mechanical ventilation
R MacLoughlin, I Martin-LoechesExpert Review of Respiratory Medicine 7 (2), 3-42, 2023202
1
2023
Antimicrobial Stewardship for Ventilator Associated Pneumonia in Intensive Care (the ASPIC trial): study protocol for a randomised controlled trial
A Foucrier, A Roquilly, D Bachelet, I Martin-Loeches, A Bougle, JF Timsit, ...BMJ open 3 (2), e065293, 2023202
1
2023
Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3 …
I Martin-Loeches, AF Shorr, RG Wunderink, MH Kollef, JF Timsit, B Yu, ...Annals of Intensive Care 3 (), 8, 2023202
1
2023
Model-interpreted outcomes of artificial neural networks classifying immune biomarkers associated with severe infections in ICU
GS Martinez, AT Ostadgavahi, AM Al-Rafat, A Garduno, R Cusack, ...Frontiers in Immunology 4, 37850, 2023202
1
2023
Characterisation of the pro-inflammatory cytokine signature in severe COVID-19
Characterisation of the pro-inflammatory cytokine signature in severe COVID-9HC Hawerkamp, AH Dyer, ND Patil, M McElheron, N O’Dowd, ...Frontiers in Immunology 4, 7002, 2023202
1
2023
Imipenem/cilastatin/relebactam efficacy, safety and probability of target attainment in adults with hospital-acquired or ventilator-associated bacterial pneumonia among …
JA Roberts, DP Nicolau, I Martin-Loeches, CA Deryke, MC Losada, J Du, ...JAC-Antimicrobial Resistance 5 (2), dlad0, 2023202
1
2023
Invasive pulmonary aspergillosis in the intensive care unit: current challenges and best practices
S Gaffney, DM Kelly, PM Rameli, E Kelleher, I Martin‐LoechesApmis, 2023202
1
2023
Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a …
Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM- inhibitor, in patients with septic shock (ASTONISH): a …B François, S Lambden, T Fivez, S Gibot, M Derive, JM Grouin, ...The Lancet Respiratory Medicine, 2023202
1
2023

Referred From: https://scholar.google.com/citations?hl=en&user=F46O3O4AAAAJ

Cited by
Citations 26200
h-index 85
i10-index 281
Recommended Journals
Open Access Journals